| Preface |
|
iii | |
|
Part A: Why, When, and How to Perform MRI of the Liver |
|
|
|
An Introduction to the Role of MRI in Liver Disease |
|
|
3 | (6) |
|
A Frame of Reference for Approaching Imaging in Liver Disease |
|
|
4 | (1) |
|
Recent Developments in MR and Other Imaging Techniques |
|
|
4 | (1) |
|
Current Choices for Imaging the Liver |
|
|
4 | (1) |
|
Defining the Appropriate Clinical Applications of Liver MRI |
|
|
5 | (1) |
|
|
|
6 | (3) |
|
Techniques for MRI of the Liver |
|
|
9 | (26) |
|
Gradients, Sampling Frequency, Bandwith, and Echo Time (TE) |
|
|
10 | (1) |
|
Parallel Acquisition Techniques |
|
|
11 | (1) |
|
Reducing Breathing Artifact |
|
|
11 | (1) |
|
Reducing Ghosting and Flow Artifacts |
|
|
12 | (1) |
|
|
|
12 | (1) |
|
|
|
12 | (1) |
|
|
|
13 | (1) |
|
|
|
13 | (1) |
|
|
|
14 | (1) |
|
Single Shot FSE Sequences |
|
|
14 | (1) |
|
|
|
15 | (1) |
|
|
|
15 | (1) |
|
True FISP/Balanced FFE Sequences |
|
|
16 | (1) |
|
|
|
16 | (1) |
|
|
|
16 | (1) |
|
|
|
16 | (1) |
|
Dynamic Gadolinium-Enhanced Imaging |
|
|
17 | (1) |
|
Imaging the Non-Compliant Patient |
|
|
17 | (1) |
|
|
|
18 | (1) |
|
|
|
18 | (17) |
|
Contrast Agents for Liver MRI |
|
|
35 | (32) |
|
Non-Specific Extra-Cellular (ECF) Gadolinium Agents |
|
|
36 | (2) |
|
Tissue-Specific Contrast Agents |
|
|
38 | (1) |
|
|
|
38 | (1) |
|
Reticulo-Endothelial System (Kupffer Cell) Agents |
|
|
39 | (2) |
|
Diagnostic Value of Contrast Agents |
|
|
41 | (1) |
|
|
|
42 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (24) |
|
Normal and Variant Anatomy, and Imaging Artifacts |
|
|
67 | (24) |
|
|
|
68 | (1) |
|
|
|
68 | (1) |
|
Segmental or Wedge-Shaped Signal Intensity Changes |
|
|
69 | (1) |
|
|
|
69 | (1) |
|
Non-Portal Venous Inflow to the Liver |
|
|
70 | (2) |
|
Lymphatic Drainage from the Liver |
|
|
72 | (1) |
|
|
|
72 | (1) |
|
Artifacts from Clips, Stents, Coils, etc |
|
|
72 | (1) |
|
|
|
73 | (1) |
|
|
|
73 | (18) |
|
Part B: MRI for Characterizing Focal Lesions in the Non-Cirrhotic Liver |
|
|
|
Cysts and Cyst-Like Lesions of the Liver |
|
|
91 | (20) |
|
|
|
92 | (1) |
|
|
|
92 | (1) |
|
Other Developmental Cysts |
|
|
92 | (1) |
|
|
|
93 | (1) |
|
Cystadenoma and Cystadenocarcinoma |
|
|
93 | (1) |
|
Hamartoma and Biliary Adenoma |
|
|
93 | (1) |
|
Differential Diagnosis of Cysts and Cyst-Like Lesions |
|
|
94 | (1) |
|
|
|
95 | (1) |
|
|
|
95 | (16) |
|
Solid Masses in the Non-Cirrhotic Liver |
|
|
111 | (64) |
|
Focal Nodular Hyperplasia |
|
|
112 | (2) |
|
|
|
114 | (2) |
|
|
|
116 | (3) |
|
|
|
119 | (1) |
|
Peripheral Cholangiocarcinoma |
|
|
119 | (1) |
|
Hepatocellular Carcinoma in the Non-Cirrhotic Liver |
|
|
119 | (1) |
|
|
|
120 | (1) |
|
|
|
121 | (1) |
|
|
|
122 | (1) |
|
|
|
122 | (1) |
|
|
|
123 | (1) |
|
|
|
123 | (52) |
|
Part C: MRI in Diffuse Liver Disease |
|
|
|
|
|
175 | (18) |
|
The Importance of Fat in Liver Disease |
|
|
176 | (1) |
|
|
|
176 | (1) |
|
|
|
176 | (1) |
|
|
|
176 | (1) |
|
Geographic Distribution of Fatty Change |
|
|
177 | (1) |
|
Tumors in the Fatty Liver |
|
|
177 | (1) |
|
|
|
178 | (1) |
|
|
|
178 | (1) |
|
|
|
178 | (15) |
|
Structural and Vascular Changes in Diffuse Liver Disease |
|
|
193 | (40) |
|
Hepatitis and Liver Fibrosis |
|
|
194 | (1) |
|
|
|
195 | (2) |
|
|
|
197 | (2) |
|
|
|
199 | (1) |
|
Portal Hypertension and Portal Vein Thrombosis |
|
|
200 | (1) |
|
Other Non-Cirrhotic Conditions Causing Disturbed Liver Architecture |
|
|
201 | (1) |
|
Nodular Regenerative Hyperplasia |
|
|
201 | (1) |
|
|
|
202 | (1) |
|
Hereditary Haemorrhagic Telangiectasia |
|
|
202 | (1) |
|
|
|
203 | (1) |
|
|
|
203 | (1) |
|
|
|
203 | (1) |
|
|
|
203 | (30) |
|
Detecting Hepatocellular Carcinoma in the Cirrhotic Liver |
|
|
233 | (34) |
|
|
|
234 | (1) |
|
|
|
234 | (1) |
|
Why Look for HCC in Cirrhosis? |
|
|
235 | (1) |
|
Who Is at High Risk of HCC in Cirrhosis? |
|
|
235 | (1) |
|
|
|
235 | (2) |
|
Non-Hepatocellular Focal Lesions in the Cirrhotic Liver |
|
|
237 | (1) |
|
An Approach to the Differential Diagnosis of Cirrhotic Nodules |
|
|
237 | (3) |
|
``Unidentified Bright Objects'' |
|
|
240 | (1) |
|
|
|
241 | (1) |
|
|
|
241 | (26) |
|
Part D: MRI in Metastatic Disease of the Liver |
|
|
|
Early Detection of Liver Metastases by MRI |
|
|
267 | (22) |
|
The Role and Value of Imaging |
|
|
268 | (1) |
|
|
|
268 | (1) |
|
The True Accuracy of Imaging |
|
|
268 | (1) |
|
Optimizing MR Technique for Detecting Small Metastases |
|
|
269 | (2) |
|
|
|
271 | (1) |
|
|
|
271 | (1) |
|
|
|
272 | (17) |
|
Characterization of Liver Metastases |
|
|
289 | (38) |
|
MR Appearances of Liver Metastases |
|
|
290 | (3) |
|
|
|
293 | (3) |
|
|
|
296 | (1) |
|
|
|
297 | (30) |
|
MRI of Liver Tumors After Treatment |
|
|
327 | (32) |
|
Post-Operative Anatomy and Surgical Residues |
|
|
328 | (1) |
|
|
|
329 | (1) |
|
Effects of Chemotherapy on Liver Parenchyma |
|
|
329 | (1) |
|
Effects of Chemotherapy on Tumors |
|
|
330 | (1) |
|
|
|
331 | (1) |
|
Transarterial Chemo-Embolization |
|
|
331 | (1) |
|
|
|
332 | (1) |
|
|
|
333 | (1) |
|
|
|
333 | (1) |
|
|
|
333 | (26) |
|
Part E: Liver MRI for Biliary Obstruction |
|
|
|
Hilar Cholangiocarcinoma and Its Mimics |
|
|
359 | (28) |
|
|
|
360 | (1) |
|
|
|
360 | (1) |
|
Morphology and Modes of Spread |
|
|
360 | (1) |
|
|
|
360 | (1) |
|
|
|
361 | (1) |
|
|
|
361 | (1) |
|
|
|
361 | (1) |
|
|
|
362 | (1) |
|
|
|
363 | (1) |
|
|
|
363 | (1) |
|
|
|
363 | (24) |
|
Some Unsolved Problems in Liver Imaging |
|
|
387 | (6) |
|
Limitations in Detecting Small Volume Disease |
|
|
388 | (2) |
|
Small Hypervascular Nodules in the Cirrhotic Liver |
|
|
390 | (1) |
|
|
|
391 | (2) |
| Index |
|
393 | |
Lisainfo e-raamatute kohta